Pages that link to "Item:Q378949"
From MaRDI portal
The following pages link to A mathematical model for the immunotherapeutic control of the Th1/Th2 imbalance in melanoma (Q378949):
Displaying 16 items.
- The re-polarisation of M2 and M1 macrophages and its role on cancer outcomes (Q304804) (← links)
- When is allergen immunotherapy effective? (Q1701583) (← links)
- Mathematical insights on psoriasis regulation: role of \(\mathrm{Th}_{1}\) and \(\mathrm{Th}_{2}\) cells (Q1714897) (← links)
- Modeling anti-tumor Th1 and Th2 immunity in the rejection of melanoma (Q1720105) (← links)
- Optimal control problem for a general reaction-diffusion tumor-immune interaction system of mixed immunotherapy and chemotherapy (Q2157844) (← links)
- Mathematical modeling of allergy and specific immunotherapy: Th1-Th2-Treg interactions (Q2261625) (← links)
- Modelling of tumor cells regression in response to chemotherapeutic treatment (Q2293851) (← links)
- Modelling of killer T-cell and cancer cell subpopulation dynamics under immuno- and chemotherapies (Q2294472) (← links)
- Response of patients with melanoma to immune checkpoint blockade -- insights gleaned from analysis of a new mathematical mechanistic model (Q2335370) (← links)
- Modelling and investigation of the \(\mathrm{CD}4^+\) T cells -- macrophages paradox in melanoma immunotherapies (Q2402514) (← links)
- A vivid cytokines interaction model on psoriasis with the effect of impulse biologic (\(\mathrm{TNF}-\alpha\) inhibitor) therapy (Q2419861) (← links)
- Dynamic Analysis of the Melanoma Model: From Cancer Persistence to Its Eradication (Q4596838) (← links)
- Treatment of Psoriasis by Interleukin-10 Through Impulsive Control Strategy: A Mathematical Study (Q4992704) (← links)
- A MODEL OF THE OPTIMAL IMMUNOTHERAPY OF PSORIASIS BY INTRODUCING IL-10 AND IL-22 INHIBITORS (Q5130470) (← links)
- Mathematics + Cancer: An Undergraduate "Bridge" Course in Applied Mathematics (Q5216251) (← links)
- A dynamical model of the immune system interaction in a melanoma (Q6156044) (← links)